Canvax Biotech has announced the development of a cellular biosensor that is one million times more sensitive than others previously developed by competitors. Some of its important benefits are that the biological system amplifies a one million times smaller signal emitted by a specimen. Also, the biosensor can detect more than one substance at a time, whether it is a drug, a chemical compound of another type or even microorganisms.
This facilitates the detection and classification of bacteria in patients with infection, allowing medical personnel to choose an appropriate antibiotic treatment much more quickly and efficiently.
For more information, read the full article here.